CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference45 articles.
1. The safety of spironolactone treatment in patients with heart failure;Anton;J. Clin. Pharm. Ther.,2003
2. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist;Arai;Eur. J. Pharmacol.,2015
3. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene;Baltatu;J. Am. Soc. Nephrol.,2002
4. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in Dahl salt-sensitive rats;Bayorh;Clin. Exp. Hypertens.,2006
5. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats;Buss;Endocrinology,2006
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An update;European Journal of Pharmacology;2024-09
2. Esaxerenone: blood pressure reduction and cardiorenal protection without reflex sympathetic activation in salt-loaded stroke-prone spontaneously hypertensive rats;Hypertension Research;2024-05-27
3. Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study;Advances in Therapy;2024-02-04
4. Gene expression analysis to identify mechanisms underlying improvement of myocardial fibrosis by finerenone in SHR;Biochemical Pharmacology;2024-02
5. Exploratory study on the relationship between urinary sodium/potassium ratio, salt intake, and the antihypertensive effect of esaxerenone: the ENaK Study;Hypertension Research;2024-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3